Pfizer BioNTech COVID-19
Pfizer BioNTech COVID-19 Vaccine is a monovalent COVID-19 vaccine that is authorized
for emergency use to prevent COVID-19 as
The first two doses of the three-dose primary series for children 6 months through 4
years of age.
A two-dose primary series for individuals 5 years of age and older.
Athird primary series dose for individuals 5 years of age and older who have been
determined to have certain kinds of immunocompromise.
Pfizer-BioNTech COVID-19 Vaccine, Bivalent is authorized for emergency use to prevent
COVID-19 as:
.The third dose of the three-dose primary series following two doses of the
monovalent Pfizer-BioNTech COVID-19 Vaccine in children 6 months through 4
years of age
. A single booster dose at least two months after completion of either primary
vaccination with any authorized or approved COVID-19 vaccine or receipt of the most
recent booster dose with any authorized or apprOved monovalent COVID-19 vaccine
in individuals 5 years of age and older.
Comments
Post a Comment